Key facts
- It has raised $9.2M; the latest was Seed Round ($9.2M) in Jun 2025.
- Notable investors include Creative Destruction Lab, Government of Ontario, MedTech Angels, Providence Health Care Ventures, INOVAIT.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Moonrise Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Moonrise Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Moonrise Medical
Developer of an artificial intelligence-enabled ultrasound technology designed to cater to the healthcare sector. The company offers an ultrasound-based device that aids in the diagnosis and evaluation of flow hemodynamics within the peripheral vascular system, with initial applications addressing peripheral artery disease (PAD) and diabetic foot ulcers (DFU), enabling patients to have an early diagnosis as well as receive guidance for treatment and interventions.
- Sector
- Healthcare
- HQ
- Hamilton, Canada
- Founded
- 2021
- Employees
- 10
- Website
- moonrisemedical.com/
- Ownership
- Privately Held (backing)
Moonrise Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Moonrise Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Moonrise Medical in its N-PORT filings yet. We sweep new filings monthly.